PSTV•benzinga•
Plus Therapeutics Granted FDA Orphan Drug Designation for For Rhenium Obisbemeda In Leptomeningeal Metastases In Patients with Lung Cancer
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on March 6, 2025 by benzinga